188 related articles for article (PubMed ID: 11641109)
21. Central nesfatin-1 reduces dark-phase food intake and gastric emptying in rats: differential role of corticotropin-releasing factor2 receptor.
Stengel A; Goebel M; Wang L; Rivier J; Kobelt P; Mönnikes H; Lambrecht NW; Taché Y
Endocrinology; 2009 Nov; 150(11):4911-9. PubMed ID: 19797401
[TBL] [Abstract][Full Text] [Related]
22. Role of CRF receptor 1 in central CRF-induced stimulation of colonic propulsion in rats.
Martínez V; Taché Y
Brain Res; 2001 Mar; 893(1-2):29-35. PubMed ID: 11222989
[TBL] [Abstract][Full Text] [Related]
23. Selective activation of corticotropin-releasing factor-2 receptors on neurochemically identified neurons in the rat dorsal raphe nucleus reveals dual actions.
Pernar L; Curtis AL; Vale WW; Rivier JE; Valentino RJ
J Neurosci; 2004 Feb; 24(6):1305-11. PubMed ID: 14960601
[TBL] [Abstract][Full Text] [Related]
24. The first extracellular domain of corticotropin releasing factor-R1 contains major binding determinants for urocortin and astressin.
Perrin MH; Sutton S; Bain DL; Berggren WT; Vale WW
Endocrinology; 1998 Feb; 139(2):566-70. PubMed ID: 9449626
[TBL] [Abstract][Full Text] [Related]
25. Comparison of an agonist, urocortin, and an antagonist, astressin, as radioligands for characterization of corticotropin-releasing factor receptors.
Perrin MH; Sutton SW; Cervini LA; Rivier JE; Vale WW
J Pharmacol Exp Ther; 1999 Feb; 288(2):729-34. PubMed ID: 9918582
[TBL] [Abstract][Full Text] [Related]
26. Peripheral injection of a new corticotropin-releasing factor (CRF) antagonist, astressin, blocks peripheral CRF- and abdominal surgery-induced delayed gastric emptying in rats.
Martínez V; Rivier J; Taché Y
J Pharmacol Exp Ther; 1999 Aug; 290(2):629-34. PubMed ID: 10411571
[TBL] [Abstract][Full Text] [Related]
27. Role of corticotropin releasing factor (CRF) receptors 1 and 2 in CRF-potentiated acoustic startle in mice.
Risbrough VB; Hauger RL; Pelleymounter MA; Geyer MA
Psychopharmacology (Berl); 2003 Nov; 170(2):178-87. PubMed ID: 12845406
[TBL] [Abstract][Full Text] [Related]
28. Central CRF inhibits gastric emptying of a nutrient solid meal in rats: the role of CRF2 receptors.
Martinez V; Barquist E; Rivier J; Taché Y
Am J Physiol; 1998 May; 274(5):G965-70. PubMed ID: 9612279
[TBL] [Abstract][Full Text] [Related]
29. Central injection of a new corticotropin-releasing factor (CRF) antagonist, astressin, blocks CRF- and stress-related alterations of gastric and colonic motor function.
Martínez V; Rivier J; Wang L; Taché Y
J Pharmacol Exp Ther; 1997 Feb; 280(2):754-60. PubMed ID: 9023288
[TBL] [Abstract][Full Text] [Related]
30. Corticotropin-releasing factor-overexpressing mice exhibit reduced neuronal activation in the arcuate nucleus and food intake in response to fasting.
Stengel A; Goebel M; Million M; Stenzel-Poore MP; Kobelt P; Mönnikes H; Taché Y; Wang L
Endocrinology; 2009 Jan; 150(1):153-60. PubMed ID: 18787020
[TBL] [Abstract][Full Text] [Related]
31. Urocortin 1 inhibits guinea pig gallbladder contractility in vitro via corticotropin-releasing factor receptor 2.
Abd El-Aziz SM; Abdel-Wahab BA
Can J Physiol Pharmacol; 2011 Nov; 89(11):783-91. PubMed ID: 22007876
[TBL] [Abstract][Full Text] [Related]
32. Urocortin promotes the development of vasculitis in a rat model of thromboangiitis obliterans via corticotrophin-releasing factor type 1 receptors.
Xu Y; Zhang R; Chen J; Zhang Q; Wang J; Hu J; Guan X; Jin L; Fu H; Gui B; Guo Y; Li S
Br J Pharmacol; 2009 Aug; 157(8):1368-79. PubMed ID: 19572944
[TBL] [Abstract][Full Text] [Related]
33. Involvement of CRH receptors in urocortin-induced hyperthermia.
Telegdy G; Adamik A
Peptides; 2008 Nov; 29(11):1937-42. PubMed ID: 18775757
[TBL] [Abstract][Full Text] [Related]
34. Delayed satiety-like actions and altered feeding microstructure by a selective type 2 corticotropin-releasing factor agonist in rats: intra-hypothalamic urocortin 3 administration reduces food intake by prolonging the post-meal interval.
Fekete EM; Inoue K; Zhao Y; Rivier JE; Vale WW; Szücs A; Koob GF; Zorrilla EP
Neuropsychopharmacology; 2007 May; 32(5):1052-68. PubMed ID: 17019404
[TBL] [Abstract][Full Text] [Related]
35. Corticotropin-releasing factor receptor subtypes mediating nutritional suppression of estrous behavior in Syrian hamsters.
Seymour PL; Dettloff SL; Jones JE; Wade GN
Am J Physiol Regul Integr Comp Physiol; 2005 Aug; 289(2):R418-R423. PubMed ID: 15831766
[TBL] [Abstract][Full Text] [Related]
36. Chronic administration of the selective corticotropin-releasing factor 1 receptor antagonist CP-154,526: behavioral, endocrine and neurochemical effects in the rat.
Arborelius L; Skelton KH; Thrivikraman KV; Plotsky PM; Schulz DW; Owens MJ
J Pharmacol Exp Ther; 2000 Aug; 294(2):588-97. PubMed ID: 10900236
[TBL] [Abstract][Full Text] [Related]
37. Effects of urocortin, corticotropin-releasing factor (CRF) receptor agonist, and astressin, CRF receptor antagonist, on the sleep-wake pattern: analysis by radiotelemetry in conscious rats.
Uchida M; Suzuki M; Shimizu K
Biol Pharm Bull; 2007 Oct; 30(10):1895-7. PubMed ID: 17917258
[TBL] [Abstract][Full Text] [Related]
38. Intravenous injection of urocortin 1 induces a CRF2 mediated increase in circulating ghrelin and glucose levels through distinct mechanisms in rats.
Wang L; Stengel A; Goebel-Stengel M; Shaikh A; Yuan PQ; Taché Y
Peptides; 2013 Jan; 39():164-70. PubMed ID: 23183626
[TBL] [Abstract][Full Text] [Related]
39. Effects of central and peripheral urocortin on fed and fasted gastroduodenal motor activity in conscious rats.
Kihara N; Fujimura M; Yamamoto I; Itoh E; Inui A; Fujimiya M
Am J Physiol Gastrointest Liver Physiol; 2001 Mar; 280(3):G406-19. PubMed ID: 11171623
[TBL] [Abstract][Full Text] [Related]
40. Activation of corticotropin-releasing factor receptor-2 causes bronchorelaxation and inhibits pulmonary inflammation in mice.
Moffatt JD; Lever R; Page CP
FASEB J; 2006 Sep; 20(11):1877-9. PubMed ID: 16855006
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
